365 related articles for article (PubMed ID: 28199343)
1. Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.
Balandraud N; Texier G; Massy E; Muis-Pistor O; Martin M; Auger I; Guzian MC; Guis S; Pham T; Roudier J
PLoS One; 2017; 12(2):e0171623. PubMed ID: 28199343
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis.
Balandraud N; Guis S; Meynard JB; Auger I; Roudier J; Roudier C
Arthritis Rheum; 2007 Jun; 57(5):762-7. PubMed ID: 17530675
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
[TBL] [Abstract][Full Text] [Related]
4. TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitis.
Couderc M; Payet S; Henquell C; Dubost JJ; Soubrier M
Joint Bone Spine; 2010 Oct; 77(5):414-7. PubMed ID: 20542718
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
Mourgues C; Henquell C; Tatar Z; Pereira B; Nourisson C; Tournadre A; Soubrier M; Couderc M
Joint Bone Spine; 2016 Jul; 83(4):412-5. PubMed ID: 26725744
[TBL] [Abstract][Full Text] [Related]
6. Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab.
Kawada J; Iwata N; Kitagawa Y; Kimura H; Ito Y
Mod Rheumatol; 2012 Aug; 22(4):565-70. PubMed ID: 22057635
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction.
Balandraud N; Meynard JB; Auger I; Sovran H; Mugnier B; Reviron D; Roudier J; Roudier C
Arthritis Rheum; 2003 May; 48(5):1223-8. PubMed ID: 12746895
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
9. Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis.
Erre GL; Mameli G; Cossu D; Muzzeddu B; Piras C; Paccagnini D; Passiu G; Sechi LA
Viral Immunol; 2015 Sep; 28(7):385-90. PubMed ID: 26083265
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of Epstein-Barr virus load and killer T cells in patients with juvenile idiopathic arthritis treated with methotrexate or tocilizumab.
Fujieda M; Tsuruga K; Sato T; Kikuchi H; Tamaki W; Ishihara M; Yamamoto M; Oishi T; Tanaka H; Daibata M
Mod Rheumatol; 2017 Jan; 27(1):66-71. PubMed ID: 27166661
[TBL] [Abstract][Full Text] [Related]
11. Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.
Wadström H; Frisell T; Askling J;
JAMA Intern Med; 2017 Nov; 177(11):1605-1612. PubMed ID: 28975211
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
[TBL] [Abstract][Full Text] [Related]
13. Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies.
Miceli-Richard C; Gestermann N; Amiel C; Sellam J; Ittah M; Pavy S; Urrutia A; Girauld I; Carcelain G; Venet A; Mariette X
Arthritis Res Ther; 2009; 11(3):R77. PubMed ID: 19470150
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
17. Serum Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis.
Kuusela E; Kouri VP; Olkkonen J; Koivuniemi R; Äyräväinen L; Rajamäki K; Valleala H; Nordström D; Leirisalo-Repo M; Ainola M; Eklund KK
Clin Exp Rheumatol; 2018; 36(5):778-784. PubMed ID: 29600942
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.
Jones G; Hall S; Bird P; Littlejohn G; Tymms K; Youssef P; Chung E; Barrett R; Button P
Int J Rheum Dis; 2018 Aug; 21(8):1581-1590. PubMed ID: 29205926
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study.
Pascart T; Philippe P; Drumez E; Deprez X; Cortet B; Duhamel A; Houvenagel E; Flipo RM
Int J Rheum Dis; 2016 Nov; 19(11):1093-1102. PubMed ID: 27018857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
